• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

John Pottage - Articles and news items

ViiV Healthcare Logo

ViiV Healthcare announces U.S. approval of Tivicay® (dolutegravir) for the treatment of HIV-1

Industry news, News / 12 August 2013 / GlaxoSmithKline

ViiV Healthcare is pleased to announce that the U.S. FDA has approved Tivicay® (dolutegravir) 50-mg tablets…

ViiV Healthcare Logo
ViiV Healthcare Logo

ViiV Healthcare announces regulatory submissions for dolutegravir in the EU, US and Canada

Industry news, News / 17 December 2012 / GlaxoSmithKline

“These regulatory submissions are an important step for ViiV Healthcare…”

GlaxoSmithKline logo
GlaxoSmithKline logo
GlaxoSmithKline logo

Shionogi-ViiV Healthcare announces initial data from pivotal phase III study of dolutegravir in HIV

Industry news, News / 2 April 2012 / GlaxoSmithKline

SPRING-2 study meets primary endpoint of non-inferiority of dolutegravir…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +